Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age - Greenberg, Richard N.; Gurtman, Alejandra; Frenck, Robert W.; Strout, Cynthia; Jansen, Kathrin U.; Trammel, James; Scott, Daniel A.; Emini, Emilio A.; Gruber, William C.; Schmoele-Thoma, Beate (Vaccine, 2014)
Keywords: Adult; adults; Age; Alcoholism; Allergy and Immunology; Applied microbiology; Bacteriology; Biological and medical sciences; Confidence intervals; Disease; Double-Blind Method; Female; Fever; Fundamental and applied biological sciences. Psychology; Humans; Immune response; Immunization Schedule; Male; Microbiology; Middle Aged; Miscellaneous; Mortality; Muscle pain; Phagocytosis; Pneumococcal conjugate vaccine; Pneumococcal Infections - prevention & control; Pneumococcal Vaccines - administration & dosage; Pneumonia; polysaccharides; Recall responses; serotypes; Streptococcus pneumoniae; Streptococcus pneumoniae - classification; vaccination; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Conjugate - administration & dosage; LOD; LLOQ; OPA; Pneumococcal conjugate vaccine; PCV; PCV13; AE; CI; CRM197; GMR; GMT; PPSV23; SAE; ACIP; Recall responses; Adult; cross-reactive material 197; geometric mean titer; CRM 197; serious adverse event; pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; lower limit of quantitation; opsonophagocytic activity; adverse event; Advisory Committee on Immunization Practices; limit of detection; geometric mean ratio; 13-valent pneumococcal conjugate vaccine; confidence interval; Streptococcaceae; Bacteria; Micrococcales; Vaccine; Polysaccharide; Age; Streptococcus pneumoniae